Captopril and hydrochlorotiazide

Mylan Laboratories

Approval Status
Approved May 1997

Treatment for

Possible similar drugs
Captopril and hydrochlorotiazide

Cardiovascular / Cardiology , Diabetes / Endocrinology

Captopril and hydrochlorothiazide tablets have been tentatively approved for the treatment of hypertension. Tablets will be manufactured in 25mg/15mg, 50mg/15mg, 25mg/25mg and 50mg/25mg strengths. This antihypertensive product is the generic equivalent of Bristol-Myers Squibb’s capozide. Shipment is scheduled to begin after the Dec. 27, 1997 expiration of Bristol-Myers Squibb’s patent.

Captopril and hydrochlorotiazide Drug Information

The Captopril and hydrochlorotiazide drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top